<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 247 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page246.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=247">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 247 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 247</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=247"><img src="../thumb/247.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>210 / 2020-04                                                           Urinary System - 16 / 16.1
                                (S3) TABS, H1941, H/18.1/2    Special precautions: Admin.in pregn.only for short periods if strict.
   16     URINARY SYSTEM        701793-007: 25 mg, 60, R91,12  indicat., monit.electrol.reg. esp.in elderly/diabet& card./hepat.or ren.
                                                                                  +
                                701807-016: 100 mg, 30, R288,70  impairm., myocard.sensitiv.to digital.incr.with K defic., perm.deafn.
                                Dosage: Adults: Essent.hypertens: Usual.50-100 mg/day. May   with ototox.meds., prostat. hyperplas., imp.micturit., K  contain./
                                                                                      +
   16.1   Diuretics             be grad.incr. at 2 wkly. interv.up to 200 mg/day. Contin.for at least 2   K spar.preps. poss.indicat.
                                                               +
                                wks.ensur. adeq. respons. Adjust dos.as necess.  Drug interactions: K -deplet.eff.enhanc.by glucocortoid/laxat.
                                                                        +
   ADCO-DAPAMAX, AI Pharm Ltd.  CHF: Init.dly.dos. of 100 mg as sngl./div.dos. Rang.from 25-200 mg   abuse, nephrotox.& ototox. eff.of cert.antibiot.(aminoglycos) potent.,
                                dly. Maint: Indiv.
                                                              anti-diabet./pres.amines potency diminish., salicylates/ theophylline/
   Indapamide.                  Sev.heart fail.in conjunct. with stand.ther. (NYHA Class III-IV):   Li & curaremimet.musc.relax.eff. potent., enhanc.eff.of antihyper-
   Indications: Mild to mod.hypertens., oed.assoc. with CHF.  Init. 25 mg once dly.in pts. with ser.K  ≤ 5,0 mmol/L & ser.creatin. ≤   tens., NSAID’s antag.act., absorpt.reduc.by sucralfate.
                                                +
   (S3) TABS. 30/7.1/0092.      220 µmol/L. May be incr.to 50 mg once dly.as clinic. indic.or reduc.to
   819417-009: 2,5 mg, 30, R18,84  25 mg every other day if not toler.  BURINEX, AI Pharm Ltd
   819417-017: 2,5 mg, 600, R376,72  Cirrhos: Usual.100 mg/day if urin.Na /K  ratio &gt; 1,0. 200-400 mg/  Bumetanide
                                                  +
                                                +
   Dosage: Hypertens: 1 tab.dly.pref.in the morn., may be incr.to   day if ratio &lt; 1,0. Maint: Indiv.  Indications: Oed.assoc.with CHF/ren.dis./ac. pulm.oed./hepat.ascit.
   2 tabs aft. 4 wks. In more sev.cases may be combin. with other cat-  Nephrot.syndr: Usual dos: 100-200 mg/day. Use only if other   (S3) TABS. G/18.1/94
   egor.of antihypertens.       ther.ineffect.                711152-005: 1 mg, 30, R181,21
   Oed: 1 tab.dly, may be incr.to 2 tabs.aft.1 wk.  Childr: Init.dos.3 mg/kg bm dly.in div.dos. Adjust accord.to re-  711152-004: 1 mg, 100, R604,15
   Contraindications: Sulphonam.-type meds. hypersens., sev.ren./   spons.& toler.  Dosage: Most.dly.dos.of 1 mg requir.giv.as sngl. morn.dos. 2  dos.
                                                                                       nd
   hepat.dysfunct., Addison’s dis., pre-exist.hypercalcaem., safety in   Diuret.-induc.hypokalaem. &/ hypomagnesaem: 25-100 mg/  may be giv.6-8 hrs.later depend. on respons. May be incr.until sat-
   pregn.& lactat.not est., concom.thiazide diuret.not recomm.  day when oral K  &/ Mg supplem.consid.inappropr.  isfact.respons. obtain.in refract. cases. Dos.to be titrat.indiv. accord.
                                       +
   Side effects: Metab.disords., electrol.imbal., GI disturbs., headache,   Diagn. & treatm. of prim.hyperaldosteronism: Init.diagnost.  to respons.& reqd.therap.activ. When control on low.dos.inadeq.init.
   dizzin., impot., photosens./ hypersens.reacts., postur.hypotens., par-  meas.while pts.are on norm.diets. Adults: Long test: 400 mg dly.for   5 mg dly.then incr. by 5 mg increm.12-24 hrly.until reqd.respons.or S/E
   aesthes., yell.vis., cholest.jaund., pancreatit., bld.dyscras.  3-4 wks. Short test: 400 mg dly.for 4 days.  appear. Consid.2xdly dos.
   Special precautions: Imp.ren./hepat.funct., discont.if azotaem.&   Short-term pre-op. prim.hyperaldosteronism treatm: Dly.  Contraindications: Anur., hepat.coma, mod.to sev.liv.fail., elec-
   oligur.occur, elderly pts. partic. suscept.to electrol.imbal., SLE may be   dos.100-400 mg bef.surg. May be giv. as longt.maint.ther.indiv.at   trol.deplet., childr.
   exacerb./activ.in suscept.pts., no exper.of use in childr.  low.effect.dos.if pts. unsuit.for surg.  Side effects: Skin rash, musc.leg cramps, abdom. discomf., throm-
   Drug interactions: Thiazide diuret.may enhance toxic.of digital.  Contraindications: Ac.ren.insuffic., rapid progress. ren.funct.im-  bocytopaen., gynaecomast., pancreatit./ sev.gener. musculoskelet.
   glycosid., enhanc.neuromusc. block. act.of competit.musc.relax., the   pairm., anur., hyperkalaem., concom. eplerenone, Addison’s dis.,   pain somet. assoc.with musc.spasm in high dos., inj.poss. aggrav.
   K deplet. eff. enhanc.by corticoster., corticotroph./ carbenoxolone &   safety in pregn.& lactat.not est.  pre-exist.electrol.imbal., uric acid incr., hear. disturbs.esp.in ren.in-
   dimin.respons.to press.amines, eff. of antihypertens.agents poss.  Side effects: Benign.breast neoplasm, leucopen., thrombocytopen.,   suff., incr.K excret.
                                                                   +
   enhanc., postur. hypotens.poss.enhanc.by concom.alcoh., barbitur./   electrol. disturbs., hyperkalaem., confus., libido chang., dizzin., somnol.,   Special precautions: Sudd.chang.in CV press./ poss.circulat.col-
   opoids, Li may lead to toxic bld.conc., NSAID’s may interfer.with ef-  GI disturbs., abnorm. hepat.funct., skin reacts., alopec., hypertrichos., leg   lapse with excess. rapid.oed. mobilisat., pre-exist.electrol.imbal.,
   fic.& enhanc risk of ren. insuff.  cramps, ac.ren.fail., gynaecomast., menstr.disords., breast pain, malaise.  high dos./ prolong.per., low salt diet, monit.bld.gluc.period.in diab./
                                                                         st
   ADCO FUROSEMIDE, AI Crit.Care  Warnings and special precautions: Anaesthes., liv.dis., hepat.  susp.latent diab., avoid in 1 trimest.of pregn., concom.antihypertens.
                                                                                     +
   Furosemide.                  coma poss.precipit.in suscept. pts., per.ser.electrol.monit., crit.K +   meds., period.ser. electrol.advis.in deplet.risk pts., high K diet in longt.
                                                                                        +
                                                                                +
                                                        +
                                                +
   Indications: Oed.of card., hepat./ren.origin, cardiogen.pulm.oed.,   monit. in pts.with sev.HF, avoid other K -spar.diurets/oral K supplem.  ther., KCl supplem.indic.in pts.where diet. K poss.inadeq., low K lev.,
                                                               +
                                                      +
   mild to mod.hypertens., forced diures.in barbit.poison., prevent.ol-  if ser.K &gt; 3,5 mmol/L, discont./interr. treatm.for ser.K  &gt;5 mmol/L or   K spar.diurets.poss. benef., discont.ther.in oligur.developm., hepat.
                                   +
                                                                                 +
                                                                          +
   igur. progress.to anur.      ser.creatin.&gt; 350 µmol/L      cirrhos., condits.assoc.with K  deplet., low K  lev.incr.myocard.sen-
   (S3) INJ. X/18.1/58. 20 mg/2 ml.  Drug interactions: Digox.half-life incr., reduc. vasc. responsiven.to   sitiv.to digital.tox.effs.
   801623-006: 10x2 ml amps, R31,00  noradrenal., reduc. diuret. eff.with aspir./other NSAIDs, antipyrine   Drug interactions: Eff.of antihypertens.meds. poss.potent.
   Dosage: IV or IM.            metabol. enhanc., hyperkalaem.metabol.acidos.with concom. am-  CATEXAN, (Unicorn) Biogaran
   Adults: 20-40 mg slow IVI, (1-2 mins) rep.if necess. aft.2 hrs.  mon.Cl & cholestyramine, decr.effic.of   Indapamide
   Pulm.oed: 40 mg slow IVI (1-2 mins.) follow.by 2nd dose 1-1½ hrs.  either agent with carbenoxolone, poss.sev. hyperkalaem.with other   Indications: Mild to mod.hypertens.
                                 +
   later depend.on respon. Childr: 1 mg/kg.  K -spar.diuret./ ACE inhibit./ angiotens.II antagon./aldosterone   (S3)TABS, 32/7.1/0406
   Contraindications: Incr.azotaem.& oligur.dur. treatm. of sev.pro-  block./ heparin, low molecul.weight hepar./ K -supplem./ K -rich   700820-005: 2,5 mg, 30, R18,30
                                                         +
                                                   +
                                   +
   gress.ren.dis., treatm.of hypovolaem. & hypotens.in hepat.coma &   diet/ K -cont.salt substit., addit.eff.with other diuret.& antihyper-  Dosage: Adult: Max.(2,5 mg)1 tab.dly.pref.in morn. May be used
   electrol. deplet. states unless basic condit. correct./ improv., lactat.,   tens.agents., poss. interfer. with digox.plasma conc.assays.  in conjunct.with other antihypertens. No exper.in use for in childr.
   safety in pregn.not est., sulphonam. hypersens.  AMILORETIC, (Aspen Pharmacare: Pharma) Pharmacare  Contraindications: Sulphonamid.derivat. hypersens., hepat.en-
   Side effects: Dehydrat.& reduc.bld.vol., electrol. disturb., revers.  cephalopathy, sev.hepat. funct. impairm./ren.fail., hypokalaem.
   deafn.& tinnit.(high dos.), skin reacts., paraesthes., blurr.vis., postur.  Amiloride HCl 5 mg, hydrochlorothiazide 50 mg.  Side effects: Common: Hypersens. reacts.esp. skin where predis-
                                Indications: Oed.of card.decompensat./assoc. with hepat.cirrhos.&
   hypotens., N&V, diarrh., dizz., headache, pancreatit., musc. spasm &   pos.to allerg/asthmat.reacts. Uncommon: Vomit., purpura. Rare:
   cramps, allerg.reacts., bld.dyscras., hyperuricaem., incr.Ca urin.excret.  corticoster.ther., essent. hypertens.  Vertigo, fatig., headache, paraesthes., naus., constip., dry mouth.
                                (S3) TABS. L/18.1/396.
   Special precautions: K-deplet.steroid ther., prostat. hypertro-  Very rare: Bld.disords., dysrhythm., hypotens., pancreatit., abnorm.
   phy/imp.micturit., imp.hepat./ ren. funct., diabet.mellit., adren.dis.  702803-014: 100, R39,49  liv.funct., angioneurot. oed.&/urticar., tox.epiderm.necrolys., Stev.
                                702803-022: 1 000, R394,89
   Interactions: Potent.cephalosporin assoc. nephrotoxic., neuromusc.  Johns.syndr., ren.fail., hypercalcaem. Not known: Syncope, myop.,
   block.act.of non-depolaris. musc.relax.enhanc., eff.of guanethidine,   Dosage: 1 tab.dly  vis.impairm., Torsade de point., hepat.encephalopathy onset in case
                                (S3) HS TABS. U/18.1/40.
   methyldopa & rauwolfia alkaloids enhanc., alcoh./barbit./narcot.may   of hepat. insuff., hepatit., ac.disseminat.LE worsen., photosens.re-
   enhanc. postur. hypotens., poss.toxic Li bld.conc.  Amiloride HCl 2,5 mg, hydrochlorothiazide 25 mg.  acts., K deplet.with hypokalaem.esp. ser. in cert.high risk pts., hy-
                                702811-009: 30, R46,27
                                                                 +
   ADCO-RETIC, AI Pharm Ltd     Dosage: 1-2  tabs.dly         ponatraem.with hypovolaem., ECG QT prolong., incr.BGC, incr.uric
   Amiloride HCl 5 mg, hydrochlorothiaz. 50 mg.  Contraindications: Pregn., sev.ren./hepat. insuff., Li-ther., hyper-  acid, elev.liv.enzym.
   Indications: Oed.of card.decompensat., hepat. cirrhos., corticoster.  kalaem., lactat., childr., porphyr.  Warnings and special precautions: Ren.funct. monit., monit.plas-
                                                                +
   ther., essent.hypertens.     Side effects: Hypo/hyperkalaem., skin rash, photosens., dizz.,   ma K /ECG with digital., avoid in pregn., excret.in breast milk, discont.
   (S3) TABS. V/18.1/260.       headache, weakn., paraesth., GI upset., bld.disords., hypochloraem.,   ther.in case of hepat. encephalopathy/photosens.reacts., protect ex-
                                                                                      +
   780618-009: 100, R35,62      cholestat. jaund., ac.pancreatit., orthostat.hypotens., low salt syndr.,   pos.areas from sun/artific.UVA if ther. re-admin. necess., K supplem.
   780618-017: 1 000, R356,19   glycosur., hyperglycaem., gout.  poss.reqd.if act.of other concom.diurets.potent., plasma sod.meas.
   Dosage: Oed: 1-2 tabs/day, once diures.achiev. attempt.reduct.for maint.  Special precautions: Ren./hepat.impairm., diabet.mellit., lact.intol.  bef. init.ther.& reg.aft., more freq.monit.in at risk pts. eg. elderly/cir-
   Hypertens: ½-1 tab dly. May be used as adjunct.to other anti-  Drug interactions: Potent.other antihypertens. drugs, incr.respons.  rhot.pts., poss.dehydrat./ orthostat. hypotens.with hyponatraem.as-
   hypertens.meds.              to tubocurarine.              soc.with hypovolaem., second.compensat.metabol.alkalos., sudd.
   Contraindications: Hyperkalaem., concom. antikaliurets.& K-sup-  hypotens.&/ac.ren.fail.risk with ACE-inhib. when ther.init.in pres.
                                                                     +
   plem., imp.ren.funct., childr., pregn.& lactat.  AUSTELL-FUROSEMIDE, Austell  of sod.deplet., K deplet.with hypokalaem. risk to be prevent.in cert.
                                Furosemide
   Side effects: Orthostat.hypotens., abn.liv.funct., pept. ulc.activat.,   high risk pts., hypokalaem.incr.card.toxic.of digital./ dysrhythm. risk,
   GI disturbs.incl.bleed., dry mouth, skin reacts., bld.disords., CV effs.,   Indications: Adjunct in ac.pulm.oed., card. oed.with other card.  poss.decr.urin.Ca excret., hypercalcaem. poss.due to prev.unrecog-
   musc. cramps, CNS eff., elev.ser.K, weakn., vertigo, paraesthes.,   ther., mild to mod.hypertens., ren.oed.in nephrot.syndr., cerebr.oed.,   nis. hyperparathyroid. in which case ther.to be withdr. bef. parathyroid
   min.psych.chang., vis.disturbs., anaphylact.-type react., fev., ne-  ascit.due to liv.cirrhos./mech.obstruct./CF, forced diures.in hypercal-  funct.investig., diabet., gout hist, lact. intol., concom.Li not recomm.,
                                                               +
   crotiz.angiit., Stev. Johns.syndr., digitalis toxic., jaund., pancreatit.,   caem.& cert.poison.treatm., in burns to reduc.loc.oed & prev.oligur.  K lev.monit. bef. init.ther.with Torsades de pointes-induc. meds./ ap-
   hyperglycaem., hyperuricaem., gout, photosens., sialadenit., resp.  progress.to anur.  propr. ther.correct.hypokalaem.if need./ ECG/ electrol. monit.dur.ther.,
   dist., malaise, chest pain, flush., nas. congest., impot., urin.disturbs.,   (S3) TABS, 37/18.1/0433  rehydrat.bef.init. ionat. contrast media.
   electrolyte imbal., poss.decr.urin.Ca, hyperkalaem., hyperparathyroid.,   707423-001: 40 mg, 30, R28,81  Interactions: Poss.reduc.eff./ac.ren.fail.risk in dehydrat. pts.with
   hypercalcaem.& hypophosphataem. with prolong.use.  Dosage: Adults:   concom.NSAIDs/COX- 2 select. inhib./ salicyl.acid.dos.≥3 g/day, incr.
   Special precautions: Part.heart block., imp.ren. /hepat.funct.,   Usual dos: 20-80 mg as sngl.dos.pef.in morn.  hypokalaem. risk with Amphotericin-B IV/gluco-& miner.syst. corticos-
   liv.dis.incl.cirrhos., diabet., poss. develop. of acidos., digital.pts.,   Oed: Init.40 mg once dly adjust.accord.to response. Mild cases: 20 mg   ter./ tetracosactide/stimul.laxat., incr. antihypertens. eff.with baclofen,
   adren.dis., discont. in case of incr.azotaem./oligur., ren.funct.test   dly.or 40 mg on alt. days. Some req.80 mg or more dly.as 1-2 dos.dly./   hypokalaem. predispos. to digital.tox.eff., incr.allopurinol hypersens.
   advis. bef.init.ther.in diabet./susp.diabet., pass. through breast milk   intermitt. Dos.up to 600 mg dly.by grad.titrat.poss. reqd.in sev.cases.  reacts., poss.hypokalaem.esp.in pts. with ren. fail./diabet.or hyper-
                                                                       +
   & cross.placenta.            Hypertens: 40-80 mg dly.      kalaem.with concom. K -spar. diurets., incr.metform.-induc.lact. acidos.
   Drug interactions: K-deplet.eff.enhanc.by corticoster., cortico-  Forced diuresis: 20-40 mg in addit.to infus.of electrol.sol.  risk, incr.ac.ren.fail.risk with large dos.of ionat. contrast med., incr.eff./
   trophin, carbenoxalone, act.of other hypertens.potent.esp.gang.  Childr: Usual dos: 1-3 mg/kg bm dly.up to max. 40 mg dly.  orthostat.hypotens.risk with TCA’s, hypercalcaem.risk with Ca salts,
   block., avoid Li (incr.toxicity risk), orthostat.hypotens.potent.by al-  Contra-indications: Sulphonam.hypersens., azotem.& oligur.dur.  incr. plasma creatin.risk with ciclosporin/tacrolimus, decr. antihyper-
   coh., barbit.& narcots., incr.respons.to tubocurarine, poss.decr.arter.  sev.progress.ren.dis.treatm., hepat.coma or electrol.deplet.states   tens.eff.with corticoster./ tetracosact., incr.plasma Li with poss.Li toxic.
   respons.to norepinephr.      until condit. correct./improv., lactat.
                                Side-effects: Bld.dyscras.incl.aplast.anaem.& agranulocytos., fluid   CIPLA INDAPAMIDE, Cipla Medpro
   ALDACTONE, Pfizer            & electrol.disturbs.e.g. hypokalaem./hyponatraem., bld.coag.disords.   Indapamide
   Spironolactone               partic.in elderly, ac. pancreatit., precip.diab.mellit., tetany, blurr.vis.,   Indications: Mild to mod.hypertens.
   Indications: Essent.hypertens., short-term pre-op prim. hyperal-  tinnit., deafn., post.hypotens., circulat.disturbs.with poss.vasc.effs.&   (S3)TABS, 31/7.1/0097
   dosteron.treatm., est. prim. hyperaldosteron. diagn.., CHF alone/  circulat. collapse, GI disturbs., skin reacts.incl.exfol. dermatit. / pho-  710313-001: 2,5 mg, 30, R19,69
   combin.with stand. ther., condits.where second. hyperaldosteron.   tosens./paraesthes.& vasculit., gout as a result of hyperuricaem.,   Dosage: Adult: 1 tab.dly.pref.in morn.aft breakf. May be used in
   pres., diuret.-induc.hypokalaem./ hypomagnesaem.as adjunct.ther.  manifestat./aggravat. of obstruct.micturit.sympts.,   conjunct.with other antihypertens. agents.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page246.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page242.html">242</a>&nbsp;&nbsp;&nbsp;<a href="page243.html">243</a>&nbsp;&nbsp;&nbsp;<a href="page244.html">244</a>&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>
             </td>
             <td width="35%"><a href="page248.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page248.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
